Spinal Cord Stimulation Reduces Ventricular Arrhythmias by Attenuating Reactive Gliosis and Activation of Spinal Interneurons

Author(s):  
Kimberly Howard-Quijano ◽  
Tomoki Yamaguchi ◽  
Fei Gao ◽  
Yuki Kuwabara ◽  
Stephanie Puig ◽  
...  
2017 ◽  
Vol 313 (2) ◽  
pp. H421-H431 ◽  
Author(s):  
Kimberly Howard-Quijano ◽  
Tatsuo Takamiya ◽  
Erica A. Dale ◽  
Jasmine Kipke ◽  
Yukiko Kubo ◽  
...  

Myocardial ischemia creates autonomic nervous system imbalance and can trigger cardiac arrhythmias. We hypothesized that neuromodulation by spinal cord stimulation (SCS) will attenuate local cardiac sympathoexcitation from ischemia-induced increases in afferent signaling, reduce ventricular arrhythmias, and improve myocardial function during acute ischemia. Yorkshire pigs ( n = 20) were randomized to SCS (50 Hz at 200-μs duration, current 90% motor threshold) or sham operation (sham) for 30 min before ischemia. A four-pole SCS lead was placed percutaneously in the epidural space (T1–T4), and a 56-electrode mesh was placed over the heart for high-resolution electrophysiological recordings, including activation recovery intervals (ARIs), activation time, repolarization time, and dispersion of repolarization. Electrophysiological and hemodynamic measures were recorded at baseline, after SCS/sham, during acute ischemia (300-s coronary artery ligation), and throughout reperfusion. SCS 1) reduced sympathoexcitation-induced ARI and repolarization time shortening in the ischemic myocardium; 2) attenuated increases in the dispersion of repolarization; 3) reduced ventricular tachyarrythmias [nonsustained ventricular tachycardias: 24 events (3 sham animals) vs. 1 event (1 SCS animal), P < 0.001]; and 4) improved myocardial function (dP/d t from baseline to ischemia: 1,814 ± 213 to 1,596 ± 282 mmHg/s in sham vs. 1,422 ± 299 to 1,380 ± 299 mmHg/s in SCS, P < 0.01). There was no change in ventricular electrophysiology during baseline conditions without myocardial stress or in the nonischemic myocardium. In conclusion, in a porcine model of acute ventricular ischemia, SCS reduced regional myocardial sympathoexcitation, decreased ventricular arrhythmias, and improved myocardial function. SCS decreased sympathetic nerve activation locally in the ischemic myocardium with no effect observed in the normal myocardium, thus providing mechanistic insights into the antiarrhythmic and myocardial protective effects of SCS. NEW & NOTEWORTHY In a porcine model of ventricular ischemia, spinal cord stimulation decreased sympathetic nerve activation regionally in ischemic myocardium with no effect on normal myocardium, demonstrating that the antiarrhythmic effects of spinal cord stimulation are likely due to attenuation of local sympathoexcitation in the ischemic myocardium and not changes in global myocardial electrophysiology.


Heart Rhythm ◽  
2012 ◽  
Vol 9 (11) ◽  
pp. 1884-1887 ◽  
Author(s):  
Roberto Grimaldi ◽  
Anna de Luca ◽  
Lilian Kornet ◽  
Davide Castagno ◽  
Fiorenzo Gaita

2014 ◽  
Vol 3 (1) ◽  
pp. 30-35 ◽  
Author(s):  
William J Hucker ◽  
Jagmeet P Singh ◽  
Kimberly Parks ◽  
Antonis A Armoundas

Alterations in resting autonomic tone can be pathogenic in many cardiovascular disease states, such as heart failure and hypertension. Indeed, autonomic modulation by way of beta-blockade is a standard treatment of these conditions. There is a significant interest in developing non-pharmacological methods of autonomic modulation as well. For instance, clinical trials of vagal stimulation and spinal cord stimulation in the treatment of heart failure are currently underway, and renal denervation has been studied recently in the treatment of resistant hypertension. Notably, autonomic stimulation is also a potent modulator of cardiac electrophysiology. Manipulating the autonomic nervous system in studies designed to treat heart failure and hypertension have revealed that autonomic modulation may have a role in the treatment of common atrial and ventricular arrhythmias as well. Experimental data on vagal nerve and spinal cord stimulation suggest that each technique may reduce ventricular arrhythmias. Similarly, renal denervation may play a role in the treatment of atrial fibrillation, as well as in controlling refractory ventricular arrhythmias. In this review, we present the current experimental and clinical data on the effect of these therapeutic modalities on cardiac electrophysiology and their potential role in arrhythmia management.


Circulation ◽  
2009 ◽  
Vol 120 (4) ◽  
pp. 286-294 ◽  
Author(s):  
John C. Lopshire ◽  
Xiaohong Zhou ◽  
Cristian Dusa ◽  
Takeshi Ueyama ◽  
Joshua Rosenberger ◽  
...  

Circulation ◽  
2005 ◽  
Vol 111 (24) ◽  
pp. 3217-3220 ◽  
Author(s):  
Ziad F. Issa ◽  
Xiaohong Zhou ◽  
Michael R. Ujhelyi ◽  
Josh Rosenberger ◽  
Deepak Bhakta ◽  
...  

2020 ◽  
Author(s):  
A Kasapovic ◽  
D Schwetje ◽  
D Cucchi ◽  
M Gathen ◽  
M Jaenisch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document